The head of the Food and Drug Administration said the agency will soon unveil a new framework detailing what companies must ...

The federal judge’s ruling has nothing to do with the merits of Kobach’s scientifically dubious argument that the vaccine isn ...

Placebo testing has been part of the process since the 1940s. It’s unclear what additional measures would achieve — but it may slow development.

A new combination vaccine could simplify protection against two major respiratory illnesses for older adults, according to a ...

A novel AI-driven method helps scientists stay ahead of viral evolution by engineering synthetic spike proteins that ...

A landmark study by scientists at the University of Oxford, has unveiled crucial insights into the way that COVID-19 vaccines mitigate severe illness in those who have been vaccinated.

A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...

The statement confused experts who said that vaccines aimed at new pathogens have always been tested this way. "That has been ...

When the Covid-19 pandemic hit, the then-Stanford professor was one of the loudest critics of lockdowns, school closures and ...

Protective efficacy was 70% in the low-dose group ... to the Serum Institute of India – which also produced the AZ COVID-19 vaccine – and the company has said it will be able to manufacture ...

Current flu vaccines generally offer only around 40% to 60% protective efficacy, but can limit the ... is also testing a vaccine that combines COVID-19 and flu in a single jab in a phase 1/2 ...

Sen. Susan Collins pressed Health and Human Services Secretary Robert F. Kennedy Jr. to defend the Trump administration's cuts to health research funding and programs to combat Alzheimer's disease ...